Lin BioScience, Inc. (TPEX:6696)
416.50
+12.00 (2.97%)
At close: Dec 5, 2025
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 34.45 billion as of December 5, 2025. Its market cap has increased by 175.59% in one year.
Market Cap
34.45B
Enterprise Value
31.77B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
416.50
Market Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 34.45B, an increase of 1,081.54%. That is a compound annual growth rate of 41.15%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 283.81B |
| PharmaEssentia | 191.21B |
| Lotus Pharmaceutical | 78.37B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Oneness Biotech | 33.97B |
| Lumosa Therapeutics | 32.68B |
| Center Laboratories | 28.03B |
| Polaris Group | 23.88B |